UK Markets open in 6 hrs 46 mins

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.24-0.07 (-1.32%)
At close: 04:00PM EDT
5.49 +0.25 (+4.77%)
After hours: 07:47PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • d
    dnwang
    Up 5% after hour, any news?
  • h
    hespe
    Are you guys still in IMGN? They just got featured on the watchlist at (http://market-engross.club)
  • F
    Frank
    Double digits incoming!
  • P
    PhD
    I love it when those who don't understand a company sell and the stock price drops on trivial news. Earnings are irrelevant for IMGN's prospects right now so a miss by a small amount is meaningless. What matters is whether IMGN can win FDA approval.
  • I
    IMHO Tep
    Approval in August? Daiichi's adc approved 4 mos before pdufa date!
  • g
    golfingarmy1
    With greatest respect to "Cardmelive" from IV board.....thank you for sharing..... here is a link to an extremely interesting article which speaks enthusiasm for the future of the ADC....

    http://www.onclive.com/view/adcs-begin-to-carve-a-place-in-the-treatment-landscape-for-ovarian-cancer
  • A
    Archimedes
    IMGN ImmunoGen failed to meet Q2 projections! Here comes the short seller's!
  • m
    marcos
    the stock took it's lumps on Friday now lets hope the analysts don't kick the horse while its down with unnecessary downgrades
  • F
    Francesco
    this perfectly straight decreasing line the graph is forming is weird, just bought 100 more xD
  • W
    Wayne
    I got in on SGEN, IMMU, IMGN, EXEL, ARIA, ARRY all about the same time, more than 20 years ago.
    Never sold a single share of ARRY, ARIA, IMMU, and all received BO offer at the end.
    Sold SGEN near 45$, and EXEL about 25$.
    Trade IMGN few times, but this time I'm not selling, I can sense approval is coming, this time is different.
    Own 15,939 shares so far, will buy more at this level.
    Good luck to all long!
  • d
    dnwang
    Well, volume increasing, on the way to $7?
  • m
    marcos
    The only way this company ever gets to 10 and I mean ever is if some company buys them out
  • P
    Peter
    Have owned 3000 shares of Immunogen since 2005. I remember Seattle Genomics was selling about two dollars more in price at the time. So since I thought both companies had comparable potentia, I chose IMGN over SGEN. According to other more knowledgeable people who post on at Investor Village message board,, seems SGEN's linking-cleaving technology is slightly more robust than that of IMGN's. Well anyway, SGEN is about to bought by Merck for a share price in excess of $200. Happy for all the patients who suffer from cancer and who have benefited from SGEN's technology, and happy for its shareholders. Sorry though that I didn't split my initial investment dollars between the two company's shares. 😢
  • m
    marcos
    @golfingarmy1 I hope it’s approved for us longs but some experts are giving it a 50/50 chance because of the lowered efficacy and I trust the guy from RBC more then anyone on the investor village board the analyst gets paid a lot of money in this case I’m hoping the 50/50 gets a yes from the FDA this stock more then any other is a pure gamble no different then going to a casino
  • E
    Eric
    today' s rise on very small volume. That let me thing market maker buy small share at big price, so small investor hope will be stimulated. That hope will bring the price higher then bigger investor will drop with bigger volumes.
  • J
    JC
    I valuebthis stock on its own recognition at $16 or $17.
    But before it gets there there are stops at 7ish and 11ish.
    BO price $25. IMO
  • J
    John D
    Between the shorts and the potential SGEN news, we are holding strong. I would guess that if SGEN gets announced, we can head for double digits because more of the big Pharma players will be watching us for the right time to purchase.
    I believe it is a year or so off and north of $75/share. IMHO
  • M
    MRI_MRS
    @Neil, did you buy your shares back?
  • J
    John D
    Frank, it looks for real this time! Looking good!
  • J
    John D
    You gotta love the after hours BS. Love the new guy who probably bought a share at 5.42???